| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/17/1994 | CA1329545C Immunological complex, its preparation and its use |
| 05/17/1994 | CA1329543C Human growth hormone formulation |
| 05/17/1994 | CA1329542C Plasma and recombinant protein formulations in low ionic strength media |
| 05/13/1994 | CA2102848A1 Altered affinity polypeptides of metal chelate binding antibodies |
| 05/11/1994 | WO1994010331A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | WO1994010317A2 Conjugate vaccine against group b streptococcus |
| 05/11/1994 | WO1994010303A1 Multidrug resistance gene |
| 05/11/1994 | WO1994010198A1 Method of reducing multidrug resistance in cells and tissues |
| 05/11/1994 | WO1994009829A1 Stable microbubble suspensions as enhancement agents for ultrasound echography |
| 05/11/1994 | WO1994009826A2 Drug delivery systems, characterised by a photolabile linkage |
| 05/11/1994 | WO1994009794A1 Ophthalmic solution and method of use |
| 05/11/1994 | WO1994009777A1 Transdermal delivery of ketorolac |
| 05/11/1994 | WO1994009760A1 Biodegradable polymers for cell transplantation |
| 05/11/1994 | WO1994009625A2 Stabilization of fluorocarbon emulsions |
| 05/11/1994 | EP0596675A1 Artificial saliva compositions |
| 05/11/1994 | EP0596304A1 Cosmetic and pharmaceutical compositions |
| 05/11/1994 | EP0596284A2 Antimycotic cosmetic and dermatological compositions containing fatty acid esters |
| 05/11/1994 | EP0596059A1 A method of controlling the oxidation of chemicals during storage using noble gases |
| 05/11/1994 | EP0596049A1 Defoaming composition |
| 05/11/1994 | EP0596011A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 05/11/1994 | EP0595854A1 Method of preparing a sterile-filterable solution of an active substance |
| 05/11/1994 | EP0396642B1 Enzyme controlled release system |
| 05/11/1994 | CN1086422A Novel compositions containing hyaluronic acid associates and a process for preparing same |
| 05/11/1994 | CA2175479A1 Drug delivery systems |
| 05/11/1994 | CA2148244A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | CA2148108A1 Ophthalmic solution and method of use |
| 05/11/1994 | CA2146926A1 Conjugate vaccine against group b streptococcus |
| 05/10/1994 | US5310881 Reaction product of mucopolysaccharides and enzymes, sustained release, drugs |
| 05/10/1994 | US5310875 Antiallergens |
| 05/10/1994 | US5310734 Comminuting cooled phosphatide to granulate |
| 05/10/1994 | US5310727 And human albumin, storage stability |
| 05/10/1994 | US5310558 Hydrophobic coating |
| 05/10/1994 | US5310538 Contrast agents |
| 05/07/1994 | CA2102547A1 Process for preparing conjugates consisting of a specific binding partner and a carbohydrate-containing protein |
| 05/05/1994 | DE4309830C1 Transdermal patches for oestradiol admin. - contg. isopropylidene mono- or di-glycerol as penetration enhancer |
| 05/04/1994 | EP0595766A1 Parenteral solutions containing diclofenac salts |
| 05/04/1994 | EP0595716A1 Enhancer for the antianemia effect of erythropoietin |
| 05/04/1994 | EP0595576A2 Stabilized sorbic acid or salt thereof |
| 05/04/1994 | EP0595226A2 Active substance-containing polymer gel |
| 05/04/1994 | EP0595133A2 Prodrugs, their preparation and use as medicaments |
| 05/04/1994 | EP0595110A1 Coating material for orally administrable forms |
| 05/04/1994 | EP0594803A1 Method for reducing side-effects of a drug |
| 05/04/1994 | EP0594770A1 Oxicam or oxicam derivatives-containing ophthalmic compositions. |
| 05/04/1994 | EP0487636B1 Process for preparation of an oil in water emulsion of a drug |
| 05/04/1994 | CN1086233A Stable magnesium hydroxide slurries |
| 05/04/1994 | CN1086144A Aqueous dispersions of zein and preparation thereof |
| 05/04/1994 | CN1086130A Stable stomach protecting microgranules of omeprazole composition and preparation of same |
| 05/04/1994 | CN1086129A Novel treatment |
| 05/04/1994 | CA2102245A1 Medication for skin diseases |
| 05/03/1994 | US5308889 Medical article for surgery |
| 05/03/1994 | US5308864 Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A |
| 05/03/1994 | US5308836 Pharmaceutical composition of stabilized [Leu13 ]-motilin-Hse |
| 05/03/1994 | US5308701 Encapsulation biological material |
| 05/03/1994 | US5308625 Nontoxic, biocompatible |
| 05/03/1994 | US5308622 Treatment of vascular injury |
| 05/03/1994 | US5308621 Ascorbic acid composition and transdermal administration method |
| 05/03/1994 | US5308620 Protein nanomatrixes and method of production |
| 05/03/1994 | US5308617 Protein heparin conjugates |
| 05/03/1994 | US5308608 Photosensitizing Diels-Alder porphyrin derivatives |
| 05/03/1994 | US5308604 Conjugates for tumor localization and/or tumor therapy |
| 05/03/1994 | CA2108808A1 Man-made saliva fluids |
| 05/03/1994 | CA1329156C Immunoglobulin conjugates |
| 05/03/1994 | CA1329130C Ranitidine |
| 05/03/1994 | CA1329121C Stabilisation of therapeutically active proteins in pharmaceutical preparations |
| 05/03/1994 | CA1329119C Cytotoxic therapy |
| 05/03/1994 | CA1329107C Emulsion compositions including amphipathic emulsifying agents |
| 05/01/1994 | CA2108920A1 Active substance-containing polymer gel |
| 04/28/1994 | WO1994009363A1 Cancer diagnosis and therapy |
| 04/28/1994 | WO1994009150A1 Monoclonal antibodies to prostate cells |
| 04/28/1994 | WO1994009136A1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/28/1994 | WO1994009106A1 Method and compositions for removing an alginate from a cutaneous substrate |
| 04/28/1994 | WO1994009034A1 Clot directed anticoagulant, process for making same and methods of use |
| 04/28/1994 | WO1994009027A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| 04/28/1994 | WO1994009003A1 Sapphyrin derivatives, conjugates and polymers thereof and expanded porphyrin chromatographic supports |
| 04/28/1994 | WO1994008627A1 Preparation of further diagnostic agents |
| 04/28/1994 | WO1994008624A2 Therapeutic and diagnostic imaging compositions and methods |
| 04/28/1994 | WO1994008623A1 Injectable lecithin gel |
| 04/28/1994 | WO1994008622A1 Pharmaceutical compositions containing a calcitonin |
| 04/28/1994 | WO1994008610A1 Pharmaceutical emulsion compositions |
| 04/28/1994 | WO1994008609A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION |
| 04/28/1994 | WO1994008605A1 Therapeutic microemulsions |
| 04/28/1994 | WO1994008603A1 Compositions |
| 04/28/1994 | WO1994008599A1 Ion-pairing of drugs for improved efficacy and delivery |
| 04/28/1994 | WO1994008596A1 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it |
| 04/28/1994 | WO1994008592A1 Lyophilized cyclophosphamide compositions |
| 04/28/1994 | WO1994008576A1 Taste-masking compositions of ranitidine |
| 04/28/1994 | WO1994008572A1 Delayed onset transdermal delivery device |
| 04/28/1994 | WO1994008571A2 Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline ingredients, and processs for producing the same |
| 04/28/1994 | WO1994008570A1 Implantable capsule |
| 04/28/1994 | WO1994008569A1 Process and device for the encapsulation of a substance |
| 04/28/1994 | WO1994008567A1 Process for the preparation of drug pellets |
| 04/28/1994 | WO1994008564A1 Composition of antineoplastic agents incorporated in micelles |
| 04/28/1994 | WO1994008563A1 Novel class of phosphocholine derivatives having antifungal activity |
| 04/28/1994 | WO1994008562A1 Sustained release compositions for treating periodontal disease |
| 04/28/1994 | WO1994008560A1 Ranitidine chewable tablets |
| 04/28/1994 | WO1994008551A2 Pharmaceutical compositions and methods for treating cold symptoms |
| 04/28/1994 | WO1993024640A3 Methods and compositions for in vivo gene therapy |
| 04/28/1994 | CA2147889A1 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it |
| 04/28/1994 | CA2147180A1 Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function |
| 04/28/1994 | CA2147151A1 Therapeutic and diagnostic imaging compositions and methods |